106 related articles for article (PubMed ID: 32642296)
1. Inflammation suppression prevents tumor cell proliferation in a mouse model of thyroid cancer.
Park S; Kim M; Zhu J; Lee WK; Altan-Bonnet G; Meltzer P; Cheng SY
Am J Cancer Res; 2020; 10(6):1857-1870. PubMed ID: 32642296
[TBL] [Abstract][Full Text] [Related]
2. Monocyte recruitment and activated inflammation are associated with thyroid carcinogenesis in a mouse model.
Park S; Zhu J; Altan-Bonnet G; Cheng SY
Am J Cancer Res; 2019; 9(7):1439-1453. PubMed ID: 31392080
[TBL] [Abstract][Full Text] [Related]
3. Metformin and JQ1 synergistically inhibit obesity-activated thyroid cancer.
Park S; Willingham MC; Qi J; Cheng SY
Endocr Relat Cancer; 2018 Oct; 25(10):865-877. PubMed ID: 29914872
[TBL] [Abstract][Full Text] [Related]
4. Activation of tumor cell proliferation by thyroid hormone in a mouse model of follicular thyroid carcinoma.
Lu C; Zhu X; Willingham MC; Cheng SY
Oncogene; 2012 Apr; 31(16):2007-16. PubMed ID: 21909131
[TBL] [Abstract][Full Text] [Related]
5. SAHA-induced loss of tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse model.
Zhu X; Kim DW; Zhao L; Willingham MC; Cheng SY
Endocr Relat Cancer; 2016 Jul; 23(7):521-33. PubMed ID: 27267120
[TBL] [Abstract][Full Text] [Related]
6. Role of TSH in the spontaneous development of asymmetrical thyroid carcinoma in mice with a targeted mutation in a single allele of the thyroid hormone-β receptor.
Zhao L; Zhu X; Won Park J; Fozzatti L; Willingham M; Cheng SY
Endocrinology; 2012 Oct; 153(10):5090-100. PubMed ID: 22919057
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of STAT3 signaling blocks obesity-induced mammary hyperplasia in a mouse model.
Park JW; Zhao L; Willingham MC; Cheng SY
Am J Cancer Res; 2017; 7(3):727-739. PubMed ID: 28401024
[TBL] [Abstract][Full Text] [Related]
8. Global expression profiling reveals gain-of-function oncogenic activity of a mutated thyroid hormone receptor in thyroid carcinogenesis.
Lu C; Mishra A; Zhu YJ; Meltzer P; Cheng SY
Am J Cancer Res; 2011; 1(2):168-191. PubMed ID: 21547001
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of STAT3 activity delays obesity-induced thyroid carcinogenesis in a mouse model.
Park JW; Han CR; Zhao L; Willingham MC; Cheng SY
Endocr Relat Cancer; 2016 Jan; 23(1):53-63. PubMed ID: 26552408
[TBL] [Abstract][Full Text] [Related]
10. Diet-induced obesity increases tumor growth and promotes anaplastic change in thyroid cancer in a mouse model.
Kim WG; Park JW; Willingham MC; Cheng SY
Endocrinology; 2013 Aug; 154(8):2936-47. PubMed ID: 23748362
[TBL] [Abstract][Full Text] [Related]
11. Genomic profiling of genes contributing to metastasis in a mouse model of thyroid follicular carcinoma.
Lu C; Mishra A; Zhu YJ; Meltzer P; Cheng SY
Am J Cancer Res; 2011 Jan; 1(1):1-13. PubMed ID: 21562609
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic Actions of the Nuclear Receptor Corepressor (NCOR1) in a Mouse Model of Thyroid Cancer.
Fozzatti L; Park JW; Zhao L; Willingham MC; Cheng SY
PLoS One; 2013; 8(6):e67954. PubMed ID: 23840792
[TBL] [Abstract][Full Text] [Related]
13. Activation of integrin-ERBB2 signaling in undifferentiated thyroid cancer.
Zhu X; Zhu YJ; Kim DW; Meltzer P; Cheng SY
Am J Cancer Res; 2014; 4(6):776-88. PubMed ID: 25520867
[TBL] [Abstract][Full Text] [Related]
14. Mutation of thyroid hormone receptor-β in mice predisposes to the development of mammary tumors.
Guigon CJ; Kim DW; Willingham MC; Cheng SY
Oncogene; 2011 Jul; 30(30):3381-90. PubMed ID: 21399657
[TBL] [Abstract][Full Text] [Related]
15. Complex temporal changes in TGFβ oncogenic signaling drive thyroid carcinogenesis in a mouse model.
Kim DW; Walker RL; Meltzer PS; Cheng SY
Carcinogenesis; 2013 Oct; 34(10):2389-400. PubMed ID: 23698635
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer.
Furuya F; Lu C; Willingham MC; Cheng SY
Carcinogenesis; 2007 Dec; 28(12):2451-8. PubMed ID: 17660507
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional telomere dynamics in follicular thyroid cancer.
Wark L; Danescu A; Natarajan S; Zhu X; Cheng SY; Hombach-Klonisch S; Mai S; Klonisch T
Thyroid; 2014 Feb; 24(2):296-304. PubMed ID: 23819464
[TBL] [Abstract][Full Text] [Related]
18. The pituitary tumor-transforming gene promotes angiogenesis in a mouse model of follicular thyroid cancer.
Kim CS; Ying H; Willingham MC; Cheng SY
Carcinogenesis; 2007 May; 28(5):932-9. PubMed ID: 17127711
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of a pexidartinib bioisostere inhibiting CSF1 production and CSF1R kinase activity in human hepatocellular carcinoma.
Awasthi BP; Guragain D; Chaudhary P; Jee JG; Kim JA; Jeong BS
Chem Biol Interact; 2023 Jan; 369():110255. PubMed ID: 36368339
[TBL] [Abstract][Full Text] [Related]
20. Gelsolin: a novel thyroid hormone receptor-beta interacting protein that modulates tumor progression in a mouse model of follicular thyroid cancer.
Kim CS; Furuya F; Ying H; Kato Y; Hanover JA; Cheng SY
Endocrinology; 2007 Mar; 148(3):1306-12. PubMed ID: 17170101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
